Test Bank:
c
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
c c c c c c c c
Edition, 2025!!!
c c
, Table of Contents c c
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines .......................................... 3
c c c c c c c c
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics................................................................... 13
c c c c
Chapter4: Pharmacogenetics and Pharmacogenomics ............................................................................... 25
c c c
Chapter 5: Pharmacology Across the Life Span ....................................................................................... 30
c c c c c c
Chapter 6: Drug-Therapy Prescribing in Special Populations .................................................................. 36
c c c c c c
Chapter 7: Drug Development and Approval ........................................................................................... 45
c c c c c
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-Substance
c c c c c c c c c
Prescribing Chapter 10: Antibiotic Stewardship ........................................................................................ 51
c c c c c
Chapter 11: Applied Calculations for Prescribing .................................................................................... 58
c c c c c
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-Focused
c c c c c c c c c
Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter 14:
c c c c c c c c c c c c
Pharmacotherapy for Eye Conditions......................................................................................................... 67
c c c c
Chapter 15: Pharmacotherapy for Skin Conditions .................................................................................. 74
c c c c c
Chapter 16: Pharmacotherapy for Neurologic Conditions ........................................................................ 81
c c c c c
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................ 94
c c c c c
Chapter 18: Pharmacotherapy for Respiratory Conditions .................................................................... 106
c c c c c
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional
c c c c c c c c
Support ..................................................................................................................................................... 117
c
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................. 128
c c c c c
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ....................... 133
c c c c c c c c c
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ........................... 146
c c c c c c c
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................. 158
c c c c c c c
Chapter 24: Pharmacotherapy for Endocrine Disorders ......................................................................... 163
c c c c c
Chapter 25: Pharmacotherapy for Hematologic Disorders ..................................................................... 174
c c c c c
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................. 190
c c c c c c c c
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions............................................... 196
c c c c c c c
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .................................................... 211
c c c c c c c
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................. 217
c c c c c c
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
c c c
Chapter 31: Antiretroviral Pharmacotherapy ........................................................................................... 235
c c c
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and
c c c c c c c c c
Neurocognitive Conditions ....................................................................................................................... 247
c c
Chapter 33: Pharmacotherapy for Pain Management ............................................................................. 257
c c c c c
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance...................................... 267
c c c c c c c c c
Chapter 35: Over-the-Counter Medications ............................................................................................. 283
c c c
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
c c c c
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
c c c c c c c c
MULTIPLE CHOICE c
• What is the primary purpose of the nursing assessment?
c c c c c c c c
A. Identifying underlying pathologic conditions c c c
B. Assisting the physician in identifying medical conditions c c c c c c
C. Determining the patients mental status c c c c
D. Exploring patient responses to health problems c c c c c
ANS: D c
A nursing assessment is done to identify the patients response to health
c c c c c c c c c c c
problems. During the nursing assessment phase, a comprehensive
c c c c c c c c
information base is developed through a physical examination, nursing
c c c c c c c c c
history, medication history, and professional observation. Identifying
c c c c c c c
underlying pathologic conditions and assisting the physician in identifying
c c c c c c c c c
medical conditions is not part of the nursing process. Determining the
c c c c c c c c c c c
patients mental status is one part of the nursing assessment, but it
c c c c c c c c c c c c
cis not the primary purpose.
c c c c
DIF: Cognitive Level: Comprehension
c c c
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
c c c c c c c c c
Process Step: Assessment
c c c
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
c c c c c c c c
• What is the basis of the NANDA I taxonomy?
c c c c c c c c
A. Functional health patterns c c
B. Human response patterns c c
C. Basic human needs c c
D. Pathophysiologic needs c
ANS: B c
The NANDA I taxonomy identifies human response patterns.
c c c c c c c
cFunctional components of health patterns are limited to activity, fluid
c c c c c c c c c
cvolume, nutrition, self care, and sensory perception. Basic human needs
c c c c c c c c c
ccomprise less than merely health patterns. Pathophysiologic needs are
c c c c c c c c
cnot part of the scope of NANDA I.
c c c c c c c
, DIF: Cognitive Level: Knowledge
c c c
REF: pp. 37-38 OBJ: 5 TOP:
c c c c c c
Nursing Process Step: Diagnosis
c c c
MSC: NCLEX Client Needs Category: Physiological Integrity
c c c c c c
• Which task is included in the assessment step of the nursing process?
c c c c c c c c c c c
A. Establishing patient goals/outcomes c c
B. Implementing the nursing care plan (NCP) c c c c c
C. Measuring goal/outcome achievement c c
D. Collecting and communicating data c c c
ANS: D c
Data are collected and communicated in the assessment phase of the
c c c c c c c c c c
cnursing process. Establishing goals is the function of planning.
c c c c c c c c
Implementing the NCP is the function of implementation. Measuring
c c c c c c c c
coutcome achievement is the function of evaluation.
c c c c c c
DIF: Cognitive Level: Comprehension
c c c
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
c c c c c c c c c
Process Step: Assessment
c c c
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
c c c c c c c c
• Which statement regarding nursing diagnoses is accurate?
c c c c c c
a. Nursing diagnoses remain the same for as long as the disease is present.
c c c c c c c c c c c c
b. Nursing diagnoses are written to identify disease states. c c c c c c c
c. Nursing diagnoses describe patient problems that nurses treat. c c c c c c c
d. Nursing diagnoses identify causes related to illness. c c c c c c
ANS: C c
Diagnostic statements identify problems a nurse is independently able to
c c c c c c c c c
treat within the scope of professional practice. Nursing diagnoses vary
c c c c c c c c c c
with the changing condition of the patient. The response patterns are
c c c c c c c c c c c
unique to the patient and are not disease specific. Nursing diagnoses
c c c c c c c c c c c
describe the patients human response pattern.
c c c c c c
DIF: Cognitive Level: Comprehension
c c c
c
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
c c c c c c c c
Edition, 2025!!!
c c
, Table of Contents c c
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines .......................................... 3
c c c c c c c c
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics................................................................... 13
c c c c
Chapter4: Pharmacogenetics and Pharmacogenomics ............................................................................... 25
c c c
Chapter 5: Pharmacology Across the Life Span ....................................................................................... 30
c c c c c c
Chapter 6: Drug-Therapy Prescribing in Special Populations .................................................................. 36
c c c c c c
Chapter 7: Drug Development and Approval ........................................................................................... 45
c c c c c
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-Substance
c c c c c c c c c
Prescribing Chapter 10: Antibiotic Stewardship ........................................................................................ 51
c c c c c
Chapter 11: Applied Calculations for Prescribing .................................................................................... 58
c c c c c
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-Focused
c c c c c c c c c
Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter 14:
c c c c c c c c c c c c
Pharmacotherapy for Eye Conditions......................................................................................................... 67
c c c c
Chapter 15: Pharmacotherapy for Skin Conditions .................................................................................. 74
c c c c c
Chapter 16: Pharmacotherapy for Neurologic Conditions ........................................................................ 81
c c c c c
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................ 94
c c c c c
Chapter 18: Pharmacotherapy for Respiratory Conditions .................................................................... 106
c c c c c
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional
c c c c c c c c
Support ..................................................................................................................................................... 117
c
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................. 128
c c c c c
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ....................... 133
c c c c c c c c c
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ........................... 146
c c c c c c c
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................. 158
c c c c c c c
Chapter 24: Pharmacotherapy for Endocrine Disorders ......................................................................... 163
c c c c c
Chapter 25: Pharmacotherapy for Hematologic Disorders ..................................................................... 174
c c c c c
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................. 190
c c c c c c c c
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions............................................... 196
c c c c c c c
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .................................................... 211
c c c c c c c
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................. 217
c c c c c c
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
c c c
Chapter 31: Antiretroviral Pharmacotherapy ........................................................................................... 235
c c c
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and
c c c c c c c c c
Neurocognitive Conditions ....................................................................................................................... 247
c c
Chapter 33: Pharmacotherapy for Pain Management ............................................................................. 257
c c c c c
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance...................................... 267
c c c c c c c c c
Chapter 35: Over-the-Counter Medications ............................................................................................. 283
c c c
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
c c c c
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
c c c c c c c c
MULTIPLE CHOICE c
• What is the primary purpose of the nursing assessment?
c c c c c c c c
A. Identifying underlying pathologic conditions c c c
B. Assisting the physician in identifying medical conditions c c c c c c
C. Determining the patients mental status c c c c
D. Exploring patient responses to health problems c c c c c
ANS: D c
A nursing assessment is done to identify the patients response to health
c c c c c c c c c c c
problems. During the nursing assessment phase, a comprehensive
c c c c c c c c
information base is developed through a physical examination, nursing
c c c c c c c c c
history, medication history, and professional observation. Identifying
c c c c c c c
underlying pathologic conditions and assisting the physician in identifying
c c c c c c c c c
medical conditions is not part of the nursing process. Determining the
c c c c c c c c c c c
patients mental status is one part of the nursing assessment, but it
c c c c c c c c c c c c
cis not the primary purpose.
c c c c
DIF: Cognitive Level: Comprehension
c c c
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
c c c c c c c c c
Process Step: Assessment
c c c
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
c c c c c c c c
• What is the basis of the NANDA I taxonomy?
c c c c c c c c
A. Functional health patterns c c
B. Human response patterns c c
C. Basic human needs c c
D. Pathophysiologic needs c
ANS: B c
The NANDA I taxonomy identifies human response patterns.
c c c c c c c
cFunctional components of health patterns are limited to activity, fluid
c c c c c c c c c
cvolume, nutrition, self care, and sensory perception. Basic human needs
c c c c c c c c c
ccomprise less than merely health patterns. Pathophysiologic needs are
c c c c c c c c
cnot part of the scope of NANDA I.
c c c c c c c
, DIF: Cognitive Level: Knowledge
c c c
REF: pp. 37-38 OBJ: 5 TOP:
c c c c c c
Nursing Process Step: Diagnosis
c c c
MSC: NCLEX Client Needs Category: Physiological Integrity
c c c c c c
• Which task is included in the assessment step of the nursing process?
c c c c c c c c c c c
A. Establishing patient goals/outcomes c c
B. Implementing the nursing care plan (NCP) c c c c c
C. Measuring goal/outcome achievement c c
D. Collecting and communicating data c c c
ANS: D c
Data are collected and communicated in the assessment phase of the
c c c c c c c c c c
cnursing process. Establishing goals is the function of planning.
c c c c c c c c
Implementing the NCP is the function of implementation. Measuring
c c c c c c c c
coutcome achievement is the function of evaluation.
c c c c c c
DIF: Cognitive Level: Comprehension
c c c
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
c c c c c c c c c
Process Step: Assessment
c c c
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
c c c c c c c c
• Which statement regarding nursing diagnoses is accurate?
c c c c c c
a. Nursing diagnoses remain the same for as long as the disease is present.
c c c c c c c c c c c c
b. Nursing diagnoses are written to identify disease states. c c c c c c c
c. Nursing diagnoses describe patient problems that nurses treat. c c c c c c c
d. Nursing diagnoses identify causes related to illness. c c c c c c
ANS: C c
Diagnostic statements identify problems a nurse is independently able to
c c c c c c c c c
treat within the scope of professional practice. Nursing diagnoses vary
c c c c c c c c c c
with the changing condition of the patient. The response patterns are
c c c c c c c c c c c
unique to the patient and are not disease specific. Nursing diagnoses
c c c c c c c c c c c
describe the patients human response pattern.
c c c c c c
DIF: Cognitive Level: Comprehension
c c c
